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Dry eye syndrome is a relatively common disease of the tears and ocular surfaces that results in discomfort, visual
disturbance, and tear film instability with possible damage to the ocular surfaces. Microvascular submandibular
gland (SMG) transfer offers a surgical alternative for a permanent autologous substitution of tears using the basal
secretion of a transplanted SMG. Long-term follow-up reveals that this technique is a lasting and effective solution
for patients with severe dry eye syndrome. The uncomfortable symptoms were relieved, and the frequency of use
of pharmaceutical tear substitutes was reduced. Objective examination showed significant improvement in tear film
and some features of ocular surface such as breakup time of tear film and corneal staining. Patients may suffer from
obstruction of Wharton's duct or epiphora after surgery. Activation of secretion-related receptors could improve the early
hypofunction of the denervated SMG and prevent the duct obstruction. Reduction surgery, partial SMG transplantation,
uses of atropine gel or Botulinum toxin A could be the choices of treatment for epiphora.
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Keratoconjunctivitis sicca (KCS), or dry eye syndrom, is
a multifactorial disease of the tears and ocular surfaces
that results in discomfort, visual disturbance, and tear
film instability with possible damage to the ocular sur-
faces [1]. The current options for treatment include arti-
ficial tear substitutes, cyclosporine eye drops, and
occlusion of tear drainage [2,3]. However, these treat-
ments have only satisfactory results in mild cases. For
severe cases of KCS, none of the routine methods of
symptom management are satisfactory [4].
Microvascular submandibular gland (SMG) transfer
with implantation of Wharton’s duct into the upper con-
junctival fornix offers a surgical alternative for a per-
manent autologous substitution of tears using the basal
secretion of a transplanted and revascularized subman-
dibular gland. This procedure was first described by
Murube-Del-Castillo in 1986 [5]. His surgical attempt
was followed by MacLeod [6], Kumar [7], Geerling [4],* Correspondence: czg4209@126.com; gyyu@263.com
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from these groups confirmed that the secretions from all
viable transplanted SMGs maintained stable function in
the long term and had been effective for severe cases of
KCS [12-17].Review
Preoperative evaluation
Before surgery, a detailed medical history questionnaire
regarding etiology, course and past treatment was taken
to assess the dry eye symptoms subjectively. Detail and
objective assessments, including ophthalmologic evalu-
ation, oral and maxillofacial evaluation and scintigraphy
with 99mTc-pertechnetate were performed. The ophthal-
mologic evaluation included best-corrected visual acuity,
Schirmer test, break-up time (BUT), and fluorescence
staining of the cornea and conjunctiva. Oral and max-
illofacial evaluation included wetting of the oral mucosa,
saliva pooling at the floor of the mouth, salivary secre-
tion at the ductal orifices of parotid and submandibular
glands. Scientigraphy with 99mTc-pertechnetate was car-
ried out to test the secretion function of submandibular
and parotid glands. Generally speaking, the SMG with apen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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[10,18,19].
The indications for the surgical procedure were that the
patients had persisting pronounced symptoms of dry eye,
that where other previous ophthalmologic treatments had
failed, and that in the ophthalmologic evaluation, Schirmer
test showed a value of <2 mm, the BUT a value of <5 sec,
and that the cornea showed positive fluorescence staining.
Contraindications were Sjőgren’s syndrome, obvious symp-
toms of xerostomia or that the whole saliva flow rate was
<0.3 g/min, and that scintigraphy showed a severe dysfunc-
tion of multiple major salivary glands [18].
Surgical procedure
Under general anaesthesia, a curved incision was made
in the temporal region (Figure 1A). An enlarged, caud-
ally based temporal flap was retracted from the layer
superficial to the superficial temporal vessels. Then the
superficial vessels were carefully dissected (Figure 1B).
The submandibular gland, including Wharton’s duct and
its related blood vessels, was harvested from the subman-
dibular triangle through a conventional cervical approach.
The dissection of the submandibular gland was taken using
an extra-capsular approach to preserve the structures of
the gland. The lower part of anterior facial vein, the prox-
imal part of facial artery and its accompanying vein were
carefully dissected and protected (Figure 1C). The chorda
tympani supplying the submandibular gland was severed,
whereas the lingual nerve was carefully protected.Figure 1 Surgical procedures of autologous microvascular submandib
Dissection of the superficial temporal vessels. (C) Dissection of the facial ar
and a cuff of mucosa around the opening. (E) Bleeding from the anterior f
evaluate the state of venous drainage from the gland. (F) The submandibu
duct. (G) Anastomosis of the vessels. (H) A nylon tube was inserted into thThe second part of the operation was performed
intraorally. A blunt probe was inserted into the duct
through its orifice to label Wharton’s duct. The mucosa
was incised between the floor of the mouth and the base
of the tongue, with a 5 cm length incision. A cuff of mu-
cosa was left intact around the duct opening (Figure 1D).
The duct was dissected and the lingual nerve was pro-
tected. The salivary duct of the sublingual gland which
joins Wharton’s duct was cut and ligated. The entire
Wharton’s duct was pulled out through the cervical sub-
mandibular access. Now the submandibular gland was re-
leased. Only the facial artery and lower part of anterior
facial vein were left, connecting the submandibular gland
to the body. The anterior facial vein was cut near the point
joining itself with the common facial vein. Bleeding from
the anterior facial vein which attached to the submandibu-
lar gland was observed to evaluate the state of venous
drainage from the gland (Figure 1E). The proximal part of
facial artery and its accompanying vein were cut at the
roots of their branches from the external carotid artery.
The submandibular gland was removed together with the
facial vessels and Wharton’s duct (Figure 1F).
Heparinized saline was irrigated into the facial artery.
The seepage of the solution from the anterior facial veins,
accompanying vein of facial artery and the vein close to
the duct was observed. The vein with most seepage of
solution was taken as the first choice for anastomosis.
Afterwards, the free submandibular gland was trans-
ferred to the temporal region. The superficial temporalular gland transplantation. (A) Incision in the temporal region. (B)
tery and its accompanying vein. (D) Dissection of the Wharton’s duct
acial vein which attached to the submandibular gland was observed to
lar gland was removed together with the facial vessels and Wharton’s
e duct.
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superficial temporal artery was anastomosed with the
facial artery by means of a 8-0 suture. The superficial
temporal vein was anastomosed with anterior facial vein
or the accompanying vein of the facial artery (Figure 1G).
Wharton’s duct was passed through a tunnel prepared
subcutaneously to the upper lateral conjunctival fornix
by blunt dissection. The distal end of Wharton’s duct
was sutured to form an opening in the upper lateral con-
junctival fold. A nylon tube was inserted into the duct and
fixed on the skin of the lateral wall of the orbit (Figure 1H)
[10,18,19].
Postoperative function regularity and ophthalmologic
assessment
In the patients with successful transplantation, the secre-
tion of the transplanted glands underwent a regular change
after transplantation. It could be divided into four stages:
transient hypofunction period (1-2 days after operation),
temporary epiphora period (3-6 days after operation), la-
tent period (1 week-3 months after operation) and function
recovery and stable period (more than 3 months after
operation) [10,20].
In the first 1-2 days after operation, very little secretion
appeared. Then hypersecretion occurred in the “temporary
epiphora period” (a mean value of 25 mm with Schirmer
test). Secretion declined gradually over the next 3 months in
“latent period” (mean value of Schirmer test, 5 mm). At last
the secretion rate picked up again and remained stable after
3 months (mean value of Schirmer test, 17 mm) [10,20].
Postoperative 99mTc-pertechnetate examination showed
that the secretory function from all viable transplanted
SMGs maintained stable function in the long term [21].
The lubricant effect of saliva appeared satisfactory with
disappearance or relief of symptoms resulting from dry
eye. The patients were able to eventually stop the applica-
tion of artificial tear substitutes. Objective examination
showed significant improvement in tear film and some
features of ocular surface such as break-up time of tear
film and corneal staining [10,13,15].
Postoperative complications
Duct obstruction
The nylon tube inserted into the duct was kept for about
10 days, to prevent scar formation between the orifice of
the duct and the conjunctiva and stricture of the duct open-
ing. In some cases in which the orifices of the left and right
Wharton’s ducts were very close to each other, harvesting
of the mucosal cuff was abandoned in order to avoid injury
to the contralateral ductal orifice. In these circumstances,
Wharton’s duct had a naked end, and the ductal wall was
directly sutured to the palpebral conjunctiva. For those
patients a polyethylene tube would be intubated and left
in the Wharton’s duct for more than 1 month.The transplanted gland is completely disconnected from
normal nerve supply during surgery. As a result, the gland
is hyposecretory for about 3 months after transplantation.
During this latent period, transplanted SMGs are at a high
risk of duct obstruction, a complication that results in in-
sufficient ocular lubrication of the treated eyes, greatly im-
pairs the effect of transplantation, and may even lead to
treatment failure. The incidence of this complication was
about 9.3% in the early phase (0–3 months) [6,10,22]. The
chronic inflammation secondary to ductal obstruction
(obstructive sialadenitis) of the transplanted SMG showed
very low secretion and recurrent swelling fo the gland.
Viscous secretions were expressed upon milking the swol-
len transplanted glands [22].
Promotion of secretion from the transplanted SMG dur-
ing the latent period is the main point for prevention of
ductal obstruction. Secretions from normal SMGs are pri-
marily evoked by the action of acetylcholine on muscarinic
receptors and adrenergic agonists on adrenoceptors [23].
In our systemic studies on secretion of SMG, a functional
expression of transient receptor potential vanilloid subtype
1 (TRPV1) was found in human and rabbit SMGs [24,25].
In the rabbit models of experimental transplanted SMG,
carbachol (an agonist of muscarinic receptors) and capsa-
icin (an agonist of TRPV1) improved secretory function of
transplanted SMG in the early stage after transplantation
[25,26].
Clinically we found that combined administration of
capsaicin and carbachol during the latent period could
significantly increase the secretion of transplanted SMG
and decrease the incidence of ductal obstruction [27].
As for the patients with duct obstruction of the trans-
planted SMG, reconstruction of the duct with venous
grat or recontouring of the duct orifice would be the
choice of treatment [10].
Epiphora
Secretion of the transplanted SMG is much more than
that of lacrimal glands. Epiphora may occur in more than
40% of the patients with total SMG transplantation, espe-
cially in those with ample SMGs and normal function be-
fore surgery [10,21]. Severe epiphora may lead to social
embarrassment and blurred vision. This probem is usually
provoked by high room temperature or physical activity
[4,28], It is usually treated by gland reduction surgery, that
is, removing approximately one third to half of the trans-
planted SMG to decrease the glandular secretion. How-
ever, the patients should undergo additional surgery after
transplantation. According to our experience, transplant-
ation of partial SMG can reduce the incidence of severe
postoperative epiphora for the patients with ample SMGs
and normal function [12]. For the patients with mild or
moderate epiphora, satisfactory treatment effect of topical
application of atropine gel could be achieved [25]. While
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epiphora. Botulinum toxin A is also used for control of
over-secretion of the transplanted SMG [29,30].
Conclusion
Microvascular SMG transfer is effective for the severe
cases of KCS. A comprehensive evaluation on the eyes
and gland is needed before surgery. The Wharton’s duct
and the related blood vessels of SMG should be har-
vested intactly in the surgery. Venous drainage from the
gland should be evaluated to choice the proper vein for
anastomosis. Patients may suffer from obstruction of
Wharton's duct or epiphora after surgery. Activation of
secretion-related receptors could improve the early
hypofunction of the denervated SMG and prevent the
duct obstruction. Reduction surgery, partial SMG trans-
plantation, uses of atropine gel or Botulinum toxin A
could be the choices of treatment for epiphora.
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